Key Points
- Oscar Health director Vanessa Ames Wittman sold 25,000 shares at an average price of $32.24, worth $806,000. The Rule 10b5-1 transaction reduced her stake by 18.23%, leaving her with 112,121 shares.
- Oscar Health reported quarterly EPS of $1.10, beating estimates of $0.40, while revenue rose 70.4% year over year to $4.88 billion. The stock opened at $30.65, down 2.1%.
- Analysts maintain a consensus “Hold” rating with an average price target of $33.90; institutional investors own approximately 75.7% of the company.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) Director Vanessa Ames Wittman sold 25,000 shares of the business's stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $32.24, for a total value of $806,000.00. Following the transaction, the director owned 112,121 shares of the company's stock, valued at $3,614,781.04. This trade represents a 18.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Oscar Health Trading Down 2.1%
Shares of NYSE OSCR opened at $30.65 on Wednesday. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $34.48. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market cap of $9.46 billion, a price-to-earnings ratio of 21.89, a PEG ratio of 0.34 and a beta of 2.37. The business's 50 day moving average price is $30.74 and its 200-day moving average price is $24.33.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.70. The company had revenue of $4.88 billion during the quarter, compared to analysts' expectations of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.Oscar Health's revenue was up 70.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.89) EPS. On average, sell-side analysts expect that Oscar Health, Inc. will post 1.83 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of research firms have recently commented on OSCR. Stephens restated an "equal weight" rating and issued a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. Bank of America raised their target price on shares of Oscar Health from $28.00 to $30.00 and gave the stock an "underperform" rating in a research report on Thursday, September 17th. Wells Fargo & Company lifted their price target on shares of Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research note on Thursday, August 13th. Piper Sandler reiterated an "overweight" rating and issued a $48.00 price target on shares of Oscar Health in a report on Thursday, September 17th. Finally, Zacks Research raised Oscar Health from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $33.90.
Read Our Latest Stock Report on OSCR
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. BIT Capital GmbH lifted its position in Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company's stock valued at $88,897,000 after acquiring an additional 5,227,152 shares during the last quarter. Geode Capital Management LLC grew its holdings in Oscar Health by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company's stock worth $68,964,000 after purchasing an additional 116,430 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Oscar Health by 22.1% during the first quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company's stock worth $48,078,000 after purchasing an additional 759,837 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock valued at $32,808,000 after purchasing an additional 1,922,732 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its position in shares of Oscar Health by 1.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,247,992 shares of the company's stock worth $35,593,000 after purchasing an additional 20,189 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company's primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.
Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
